Interactive Financial Charts Not Available

Ge Healthcare (GEHC) | Financial Analysis & Statements

Ge Healthcare Technologies Inc. | Large-cap | Healthcare

$73.40

-0.35%

Ge Healthcare vs Veeva Systems Ge Healthcare vs Tempus AI Ge Healthcare vs Doximity Ge Healthcare vs HealthEquity Ge Healthcare vs Waystar Holding Ge Healthcare vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 4.8B

Gross Profit 2.0B 42.12%

Operating Income 628.0M 13.15%

Net Income 588.0M 12.31%

Balance Sheet Metrics

Total Assets 33.6B

Total Liabilities 24.2B

Shareholders Equity 9.4B

Debt to Equity 2.57

Cash Flow Metrics

Operating Cash Flow 509.0M

Free Cash Flow 98.0M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Ge Healthcare Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue i	19.7B	19.6B	18.3B	17.6B	17.2B
Cost of Goods Sold i	11.5B	11.6B	11.2B	10.4B	10.4B
Gross Profit i	8.2B	7.9B	7.2B	7.2B	6.8B
Gross Margin % i	41.7%	40.5%	39.1%	40.8%	39.4%
Operating Expenses
Research & Development i	1.3B	1.2B	1.0B	816.0M	810.0M
Selling, General & Administrative i	4.3B	4.3B	3.6B	3.6B	3.2B
Other Operating Expenses i	-	-	-	-	-
Total Operating Expenses i	5.6B	5.5B	4.7B	4.4B	4.0B
Operating Income i	2.6B	2.4B	2.5B	2.8B	2.7B
Operating Margin % i	13.3%	12.5%	13.8%	15.9%	15.8%
Non-Operating Items
Interest Income i	-	26.0M	-	34.0M	49.0M
Interest Expense i	505.0M	542.0M	86.0M	40.0M	66.0M
Other Non-Operating Income	462.0M	442.0M	76.0M	86.0M	7.0M
Pre-tax Income i	2.6B	2.4B	2.5B	2.9B	2.7B
Income Tax i	531.0M	743.0M	563.0M	600.0M	652.0M
Effective Tax Rate % i	20.6%	31.5%	22.4%	20.9%	24.1%
Net Income i	2.0B	1.6B	2.0B	2.3B	13.9B
Net Margin % i	10.4%	8.3%	10.7%	13.0%	81.0%
Key Metrics
EBITDA i	3.7B	3.5B	3.2B	3.5B	3.4B
EPS (Basic) i	$4.37	$3.05	$4.63	$4.94	$30.45
EPS (Diluted) i	$4.34	$3.03	$4.63	$4.94	$30.45
Basic Shares Outstanding i	456000000	455000000	413822894	454710004	454710004
Diluted Shares Outstanding i	456000000	455000000	413822894	454710004	454710004

Income Statement Trend

Ge Healthcare Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets
Cash & Equivalents i	2.9B	2.5B	1.4B	554.0M	994.0M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	3.4B	3.3B	3.1B	3.0B	1.6B
Inventory i	1.9B	2.0B	2.2B	1.9B	1.6B
Other Current Assets	12.0M	61.0M	94.0M	88.0M	98.0M
Total Current Assets i	9.9B	9.4B	8.3B	7.0B	5.9B
Non-Current Assets
Property, Plant & Equipment i	364.0M	356.0M	313.0M	358.0M	405.0M
Goodwill i	27.4B	27.1B	27.1B	27.6B	25.3B
Intangible Assets i	1.1B	1.3B	1.5B	1.8B	1.6B
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	5.4B	5.3B	2.2B	2.0B	2.3B
Total Non-Current Assets i	23.2B	23.0B	19.2B	19.3B	18.3B
Total Assets i	33.1B	32.5B	27.5B	26.3B	24.2B
Liabilities
Current Liabilities
Accounts Payable i	3.0B	2.9B	2.9B	2.5B	2.2B
Short-term Debt i	1.6B	1.1B	119.0M	110.0M	132.0M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	711.0M	951.0M	804.0M	860.0M	943.0M
Total Current Liabilities i	9.6B	9.0B	7.2B	6.8B	6.5B
Non-Current Liabilities
Long-term Debt i	7.8B	8.7B	8.5B	327.0M	336.0M
Deferred Tax Liabilities i	56.0M	68.0M	370.0M	385.0M	459.0M
Other Non-Current Liabilities	208.0M	460.0M	321.0M	318.0M	558.0M
Total Non-Current Liabilities i	14.9B	16.2B	10.8B	2.7B	3.0B
Total Liabilities i	24.4B	25.1B	17.9B	9.4B	9.5B
Equity
Common Stock i	5.0M	5.0M	11.2B	17.7B	15.6B
Retained Earnings i	3.3B	1.3B	0	-	-
Treasury Stock i	25.0M	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	8.7B	7.3B	9.6B	16.9B	14.8B
Key Metrics
Total Debt i	9.4B	9.9B	8.6B	437.0M	468.0M
Working Capital i	348.0M	429.0M	1.1B	239.0M	-628.0M

Balance Sheet Composition

Ge Healthcare Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income i	2.0B	1.6B	1.9B	2.3B	2.1B
Depreciation & Amortization i	580.0M	610.0M	633.0M	625.0M	630.0M
Stock-Based Compensation i	125.0M	114.0M	67.0M	76.0M	-
Working Capital Changes i	2.0M	-47.0M	-223.0M	-1.3B	42.0M
Operating Cash Flow i	3.2B	3.3B	3.0B	2.2B	2.7B
Investing Activities
Capital Expenditures i	-401.0M	-386.0M	-306.0M	-233.0M	-221.0M
Acquisitions i	-313.0M	-147.0M	0	-1.5B	-78.0M
Investment Purchases i	-40.0M	-	-	-	-
Investment Sales i	-	-	-	-	-
Investing Cash Flow i	-914.0M	-558.0M	-398.0M	-1.8B	-301.0M
Financing Activities
Share Repurchases i	-	-	-	-	-
Dividends Paid i	-55.0M	-41.0M	0	0	-
Debt Issuance i	995.0M	2.0B	8.2B	5.0M	4.0M
Debt Repayment i	-1.4B	-855.0M	-3.0M	-10.0M	-20.0M
Financing Cash Flow i	-606.0M	-478.0M	-822.0M	-263.0M	-2.2B
Free Cash Flow i	1.6B	1.7B	1.8B	1.4B	1.4B
Net Change in Cash i	1.7B	2.3B	1.8B	214.0M	239.0M

Cash Flow Trend

Ge Healthcare Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.25

Forward P/E 15.93

Price to Book 3.50

Price to Sales 1.70

PEG Ratio 15.93

Profitability Ratios

Profit Margin 11.22%

Operating Margin 14.62%

Return on Equity 25.80%

Return on Assets 5.77%

Financial Health

Current Ratio 1.16

Debt to Equity 107.67

Beta 1.28

Per Share Data

EPS (TTM) $4.88

Book Value per Share $21.27

Revenue per Share $43.74

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
gehc	34.0B	15.25	3.50	25.80%	11.22%	107.67
Veeva Systems	45.6B	59.15	7.33	14.06%	27.34%	1.24
Tempus AI	12.4B	33.14	39.94	-97.95%	-20.98%	275.63
Doximity	11.6B	52.84	11.30	24.25%	39.88%	1.16
HealthEquity	7.7B	65.16	3.64	5.77%	9.80%	52.11
Waystar Holding	6.2B	64.55	1.95	2.81%	8.50%	39.60

Financial data is updated regularly. All figures are in the company's reporting currency.